Savara to present at jefferies healthcare conference

Austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the jefferies healthcare conference on june 8, 2022 at 1:00 pm et in new york city. a live webcast of the presentation will be available on savara's website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days. about savara savara is a clinical stage biopharmaceuti
SVRA Ratings Summary
SVRA Quant Ranking